Bone Tissue Engineering in the Growing Calvaria Using Dipyridamole-Coated, Three-Dimensionally-Printed Bioceramic Scaffolds: Construct Optimization and Effects on Cranial Suture Patency.

BACKGROUND Three-dimensionally-printed bioceramic scaffolds composed of β-tricalcium phosphate delivering the osteogenic agent dipyridamole can heal critically sized calvarial defects in skeletally mature translational models. However, this construct has yet to be applied to growing craniofacial models. In this study, the authors implanted three-dimensionally-printed bioceramic/dipyridamole scaffolds in a growing calvaria animal model and evaluated bone growth as a function of geometric scaffold design and dipyridamole concentration. Potential adverse effects on the growing suture were also evaluated. METHODS Bilateral calvarial defects (10 mm) were created in 5-week-old (approximately 1.1 kg) New Zealand White rabbits (n = 16 analyzed). Three-dimensionally-printed bioceramic scaffolds were constructed in quadrant form composed of varying pore dimensions (220, 330, and 500 μm). Each scaffold was coated with collagen and soaked in varying concentrations of dipyridamole (100, 1000, and 10,000 μM). Controls consisted of empty defects. Animals were killed 8 weeks postoperatively. Calvariae were analyzed using micro-computed tomography, three-dimensional reconstruction, and nondecalcified histologic sectioning. RESULTS Scaffold-induced bone growth was statistically greater than bone growth in empty defects (p = 0.02). Large scaffold pores, 500 μm, coated in 1000 μM dipyridamole yielded the most bone growth and lowest degree of scaffold presence within the defect. Histology showed vascularized woven and lamellar bone along with initial formation of vascular canals within the scaffold lattice. Micro-computed tomographic and histologic analysis revealed patent calvarial sutures without evidence of ectopic bone formation across all dipyridamole concentrations. CONCLUSION The authors present an effective pediatric bone tissue-engineering scaffold design and dipyridamole concentration that is effective in augmentation of calvarial bone generation while preserving cranial suture patency.

[1]  P. Coelho,et al.  In vivo evaluation of resorbable supercritical CO2 -treated collagen membranes for class III furcation-guided tissue regeneration. , 2018, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  Geng-sheng Shi,et al.  Effects of rhBMP-2/7 Heterodimer and RADA16 Hydrogel Scaffold on Bone Formation During Rabbit Mandibular Distraction. , 2018, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[3]  Christopher D Lopez,et al.  Three dimensionally printed bioactive ceramic scaffold osseoconduction across critical-sized mandibular defects. , 2018, The Journal of surgical research.

[4]  Nathaniel S. Hwang,et al.  Biomimetic Materials and Fabrication Approaches for Bone Tissue Engineering , 2017, Advanced healthcare materials.

[5]  Christopher D Lopez,et al.  Dipyridamole enhances osteogenesis of three-dimensionally printed bioactive ceramic scaffolds in calvarial defects. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[6]  M. Urata,et al.  Three-Dimensional Cone Beam Computed Tomography Volumetric Outcomes of rhBMP-2/Demineralized Bone Matrix versus Iliac Crest Bone Graft for Alveolar Cleft Reconstruction. , 2017, Plastic and reconstructive surgery.

[7]  John L Ricci,et al.  Bone regeneration in critical bone defects using three-dimensionally printed β-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. , 2017, Journal of biomedical materials research. Part B, Applied biomaterials.

[8]  B. Cronstein,et al.  Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine‐dependent mechanism , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  P. Coelho,et al.  Implant design and its effects on osseointegration over time within cortical and trabecular bone. , 2016, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  Francesco Baino,et al.  Bioceramics and Scaffolds: A Winning Combination for Tissue Engineering , 2015, Front. Bioeng. Biotechnol..

[11]  Yuan Yuan,et al.  β-Tricalcium phosphate/poly(glycerol sebacate) scaffolds with robust mechanical property for bone tissue engineering. , 2015, Materials science & engineering. C, Materials for biological applications.

[12]  José Manuel García-Aznar,et al.  In silico Mechano-Chemical Model of Bone Healing for the Regeneration of Critical Defects: The Effect of BMP-2 , 2015, PloS one.

[13]  Chengtie Wu,et al.  In vivo experimental study on bone regeneration in critical bone defects using PIB nanogels/boron-containing mesoporous bioactive glass composite scaffold , 2015, International journal of nanomedicine.

[14]  B. Cronstein,et al.  Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein‐2 , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Paulo G Coelho,et al.  Osseointegration of metallic devices: current trends based on implant hardware design. , 2014, Archives of biochemistry and biophysics.

[16]  A. Almarza,et al.  BMP-2–Regenerated Calvarial Bone: A Biomechanical Appraisal in a Large Animal Model , 2014, Annals of plastic surgery.

[17]  Jason A Inzana,et al.  3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. , 2014, Biomaterials.

[18]  Shuping Peng,et al.  Current Progress in Bioactive Ceramic Scaffolds for Bone Repair and Regeneration , 2014, International journal of molecular sciences.

[19]  D. Kaplan,et al.  VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. , 2014, European cells & materials.

[20]  A. A. Zadpoor,et al.  Enhanced bone regeneration of cortical segmental bone defects using porous titanium scaffolds incorporated with colloidal gelatin gels for time- and dose-controlled delivery of dual growth factors. , 2013, Tissue engineering. Part A.

[21]  J. Ong,et al.  Sintering effects on chemical and physical properties of bioactive ceramics , 2013, Journal of Advanced Ceramics.

[22]  B. Cronstein,et al.  Adenosine A2A receptor (A2AR) is a fine-tune regulator of the collagen1:collagen3 balance , 2013, Purinergic Signalling.

[23]  J. Riva-Cambrin,et al.  Risk factors and rates of bone flap resorption in pediatric patients after decompressive craniectomy for traumatic brain injury. , 2013, Journal of neurosurgery. Pediatrics.

[24]  Jordan C. Deschamps-Braly,et al.  Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein 2 on Cranial Defect Closure in the Pediatric Population , 2013, The Journal of craniofacial surgery.

[25]  Peter Greil,et al.  Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions , 2012, Journal of cellular and molecular medicine.

[26]  A. Molenberg,et al.  PEG matrix enables cell-mediated local BMP-2 gene delivery and increased bone formation in a porcine critical size defect model of craniofacial bone regeneration. , 2012, Clinical oral implants research.

[27]  B. Cronstein,et al.  Adenosine A2A Receptor Activation Prevents Wear Particle–Induced Osteolysis , 2012, Science Translational Medicine.

[28]  B. Cronstein,et al.  Adenosine A(2A) receptor ligation inhibits osteoclast formation. , 2012, The American journal of pathology.

[29]  S. Buchman,et al.  Current and Emerging Basic Science Concepts in Bone Biology: Implications in Craniofacial Surgery , 2012, The Journal of craniofacial surgery.

[30]  P. Correia‐de‐Sá,et al.  On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells , 2011, Journal of cellular physiology.

[31]  A. Sharan,et al.  Effect of Early Surgery, Material, and Method of Flap Preservation on Cranioplasty Infections: A Systematic Review , 2011, Neurosurgery.

[32]  A. Burrows,et al.  Recombinant Human Bone Morphogenetic Protein-2–Induced Craniosynostosis and Growth Restriction in the Immature Skeleton , 2011, Plastic and reconstructive surgery.

[33]  A. Schilling,et al.  BMP‐7–induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6‐mice , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  C. Philippe,et al.  Could an osteoinductor result in degeneration of a neurofibroma in NF1? , 2010, European Spine Journal.

[35]  Hermann Seitz,et al.  Ceramic scaffolds produced by computer-assisted 3D printing and sintering: characterization and biocompatibility investigations. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[36]  H. Diener,et al.  Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial , 2010, The Lancet Neurology.

[37]  Vishal Gupta,et al.  Comparative Evaluation of Autogenous Calvarial Bone Graft and Alloplastic Materials for Secondary Reconstruction of Cranial Defects , 2010, The Journal of craniofacial surgery.

[38]  K. Salyer.  Primary reconstruction of alveolar clefts using recombinant human bone morphogenic protein-2: clinical and radiographic outcomes. , 2009, The Journal of craniofacial surgery.

[39]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering , 2009, Biotechnology Letters.

[40]  Pierre Layrolle,et al.  Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. , 2009, Journal of biomedical materials research. Part A.

[41]  Alan S Herford,et al.  Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). , 2008, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[42]  Chi-Hwa Wang,et al.  Optimized bone regeneration based on sustained release from three‐dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP‐2 , 2008, Biotechnology and bioengineering.

[43]  E. D. Rekow,et al.  In vivo bone response to 3D periodic hydroxyapatite scaffolds assembled by direct ink writing. , 2007, Journal of biomedical materials research. Part A.

[44]  Y. Tabata,et al.  Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. , 2007, Tissue engineering.

[45]  Myron Nevins,et al.  De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. , 2005, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[46]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[47]  David S Baskin,et al.  A Prospective, Randomized, Controlled Cervical Fusion Study Using Recombinant Human Bone Morphogenetic Protein-2 With the CORNERSTONE-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate , 2003, Spine.

[48]  C T Laurencin,et al.  Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. , 2001, Biomaterials.

[49]  T. Mao,et al.  An experimental study on rhBMP-2 composite bone substitute for repairing craniomaxillary bone defects. , 1998, The Chinese journal of dental research : the official journal of the Scientific Section of the Chinese Stomatological Association.

[50]  H. Bengtsson,et al.  Bone morphogenetic proteins and their receptors: Potential functions in the brain , 1998, Journal of neuroscience research.

[51]  D. Restrepo,et al.  Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents. , 1987, The Annals of thoracic surgery.

[52]  J. Zerwekh,et al.  Granular tricalcium phosphate in large cancellous defects. , 1986, Annals of clinical and laboratory science.

[53]  T. Yasaki,et al.  Effect of dipyridamole treatment on proteinuria in pediatric renal disease. , 1986, Nephron.

[54]  J. Stamler,et al.  Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.

[55]  H. Yoshikawa,et al.  BMP-2/7 heterodimer strongly induces bone regeneration in the absence of increased soft tissue inflammation. , 2018, The spine journal : official journal of the North American Spine Society.

[56]  S. Stock,et al.  Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. , 2013, Biomaterials.

[57]  P. Coelho,et al.  Effect of drilling dimension on implant placement torque and early osseointegration stages: an experimental study in dogs. , 2012, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[58]  G. Rogers,et al.  Autogenous bone graft: basic science and clinical implications. , 2012, The Journal of craniofacial surgery.

[59]  D. Cho,et al.  Bone regeneration using a microstereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres. , 2011, Biomaterials.

[60]  Y. Ikada,et al.  Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution. , 1998, Journal of biomaterials science. Polymer edition.

[61]  K. Salyer,et al.  Bone grafts in craniofacial surgery. , 1987, Clinics in plastic surgery.